Zhejiang Cheng Yi Pharmaceutical(603811.SH): The injection of Doxofylline Hydrochloride and Pentamine Hydrochloride has passed the consistency evaluation of generic drugs.

Zhejiang Cheng Yi Pharmaceutical (603811.SH) announced that it has recently received the Approval Notice for Drug Supplementary Application issued by the National Medical Products Administration. The company's Dobutamine Hydrochloride Injection has passed the evaluation of generic drug quality and efficacy consistency. Dobutamine Hydrochloride Injection is mainly used for heart failure caused by reduced myocardial contractility in organic heart disease, including low cardiac output syndrome caused by cardiac surgery, as a short-term supportive therapy.